Delivery Order SPE2DR25D3401-SPE2DR26FL0LM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,260.01 on December 4, 2025, for the supply of epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed price delivery order with an ultimate completion date of December 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract carries a ceiling value of $1,288.24 and has a firm fixed price structure with an ultimate completion date of November 17, 2025. The award was issued from the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.22 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency has awarded a delivery order valued at $1,797.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date is November 18, 2025, with the award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,374.28 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price delivery order, which is not set-aside, represents a relatively small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, with a completion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $17,864.44 delivery order on August 28, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The delivery order represents a discrete fulfillment under the company's existing contract vehicle...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,865.81 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 MG auto-injector two-packs. This competitive award, with an ultimate completion date of September 3, 2025, was issued as a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.57 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was issued to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two units per pack). This firm fixed price delivery order, valued at $4,035.65, represents a non-set-aside competitive award with an ultimate completion date of October 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0LMDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,716.00 for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor within the DLA's medical supply chain infrastructure. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The prime vendor arrangement supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key participant in the DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/4/25 |